Skip to main content

UBS Group AG

Position in IBRX — ImmunityBio, Inc.

CIK 1610520 ZURICH, V8

Position in IBRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$27,978,598
+$5,391,309 QoQ
Shares Held
3,195,728
+8.5% QoQ
Ownership
0.302%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 403 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 56% Shared 0% None 44%

Common Shares in IBRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. IBRX ranks #58 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IBRX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $27,978,598 3,195,728
2026-03-31 $22,587,289 2,944,888
2025-12-31 $3,951,300 1,995,607
2025-09-30 $4,134,231 1,680,582
2025-06-30 $3,143,307 1,190,647
2025-03-31 $4,329,630 1,438,416
2024-12-31 $4,064,483 1,587,689
2024-09-30 $1,511,930 406,433
2024-06-30 $2,896,170 458,255
2024-03-31 $4,969,875 925,489
2023-12-31 $214,414 42,712
2023-09-30 $67,231 39,782
2023-06-30 $110,399 39,712
2023-03-31 $208,167 114,378
2022-12-31 $1,868,816 368,603
2022-09-30 $576,111 115,918
2022-06-30 $186,271 50,073
2022-03-31 $970,696 173,030
2021-12-31 $2,158,320 354,987
2021-09-30 $2,714,527 278,699
2021-06-30 $388,115 27,179
2021-03-31 $1,329,771 56,014
2020-12-31 NK 5,156
2020-09-30 NK 10,415
2020-06-30 NK 15,712
2020-03-31 NK 5,550